iPLATO Experiences Strong Support from Clinical Commissioning Groups

iPLATO HealthcareiPLATO, a leader in mHealth and Analytics, reports strong support from CCGs - the new healthcare commissioners in England. Following explosive growth in new patients and primary care practices over the last year the company reports 100% renewal rates for CCGs on iPLATO Enterprise in 2012/13. iPLATO attributes its ability to retain customers to market leading technology and support combined with relentless focus on innovation to improve outcomes.

In addition to high retention rates of our commissioning partners, iPLATO has experienced a stronger long term commitment to mHealth with half of its CCG partners up for renewal over the last six months of the NHS financial year moving from one to three year subscriptions.

"Considering the organisational turmoil when PCTs where abolished and CCGs picked up the commissioning baton, it is remarkable that we renewed every single one of our many CCG partners in 2012/13," said Tobias Alpsten, CEO of iPLATO Healthcare. "For a cloud computing business like ours it is crucial that we hold onto our existing customers year-on-year whilst adding new partners. Clearly, this would not have happened without strong and vocal support from many leading GP practices."

"That fact that half of our CCGs have moved from one to three year contracts is a sign that iPLATO is becoming part of the strategic plans for A&E avoidance, patient engagement and long term condition management. Lead by companies like iPLATO, the use of Analytics to target patients and interventions combined with mHealth as an engagement mechanism is only just beginning to realise its enormous potential."

Related news articles:

About iPLATO
iPLATO Healthcare is British innovation company dedicated to mHealth and Analytics since 2006.

iPLATO's evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.

Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and pandemic awareness as well as mobile disease management services for people with diabetes, hypertension, epilepsy and HIV.

iPLATO Healthcare's mission is to, in partnership with clinicians, help healthcare commissioners transform patient care through cloud based mHealth and Analytics.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...